Details for New Drug Application (NDA): 214794
✉ Email this page to a colleague
The generic ingredient in DEXMEDETOMIDINE HYDROCHLORIDE is dexmedetomidine hydrochloride. There are fourteen drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the dexmedetomidine hydrochloride profile page.
Summary for 214794
Tradename: | DEXMEDETOMIDINE HYDROCHLORIDE |
Applicant: | Piramal Critical |
Ingredient: | dexmedetomidine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 214794
Mechanism of Action | Adrenergic alpha2-Agonists |
Physiological Effect | General Anesthesia |
Medical Subject Heading (MeSH) Categories for 214794
Suppliers and Packaging for NDA: 214794
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 214794 | ANDA | Piramal Critical Care Inc | 66794-238 | 66794-238-41 | 25 VIAL in 1 CARTON (66794-238-41) / 2 mL in 1 VIAL (66794-238-02) |
DEXMEDETOMIDINE HYDROCHLORIDE | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 214794 | ANDA | Piramal Critical Care Inc | 66794-238 | 66794-238-43 | 10 VIAL in 1 CARTON (66794-238-43) / 2 mL in 1 VIAL (66794-238-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 200MCG BASE/2ML (EQ 100MCG BASE/ML) | ||||
Approval Date: | Sep 3, 2021 | TE: | RLD: | No |
Complete Access Available with Subscription